Zuo Jin Wan Reverses the Resistance of Colorectal Cancer to Oxaliplatin by Regulating the MALAT1/miR-200s/JNK Signaling Pathway

BACKGROUND: Oxaliplatin (L-OHP) is a common chemotherapy drug used in the treatment of colorectal cancer (CRC). Our previous work showed that Zuo Jin Wan (ZJW), a traditional Chinese medicine prescription, could improve sensitivity to L-OHP in the treatment of CRC, but the detailed mechanism is not...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Zhenzhen, Zhou, Jing, Yu, Hao, Pu, Yunzhou, Cheng, Yuelei, Zhang, Yi, Ji, Qing, Zhu, Huirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568309/
https://www.ncbi.nlm.nih.gov/pubmed/36248422
http://dx.doi.org/10.1155/2022/3032407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568309/
https://www.ncbi.nlm.nih.gov/pubmed/36248422
http://dx.doi.org/10.1155/2022/3032407

Ejemplares similares